Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
As a result of the different event rates in the two studies, the median durations of follow-up were also substantially different (3.8 years in LEADER vs
The opportunity is significant given Indias large metabolic disease burden 77 M diabetics (9095% Type-2) and nearly 180M overweight or obese adults
Key secondary endpoints include minimal disease activity and the composite of ACR50 + PASI100 (complete skin clearance) at Week 16, which means they're measuring both joint and skin outcomes simultaneously
Yes, we offer Semaglutide-based treatments, including Wegovy, depending on patient eligibility and clinical evaluation
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
